Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FTO | Q9C0B1 | 8/20 | 0.73 |
| ▸ | MEN1 | O00255 | 5/20 | 0.73 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.73 |
| ▸ | MAPT | P10636 | 5/20 | 0.73 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.73 |
| ▸ | RECQL | P46063 | 2/20 | 0.73 |
| ▸ | BLM | P54132 | 2/20 | 0.73 |
| ▸ | ACE2 | Q9BYF1 | 2/20 | 0.73 |
| ▸ | HTT | P42858 | 2/20 | 0.73 |
| ▸ | PRMT1 | Q99873 | 2/20 | 0.73 |
| ▸ | HPGD | P15428 | 2/20 | 0.73 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.73 |
| ▸ | SMAD3 | P84022 | 1/20 | 0.73 |
| ▸ | GNG2 | P59768 | 1/20 | 0.58 |
| ▸ | GNB1 | P62873 | 1/20 | 0.58 |
| ▸ | USP2 | O75604 | 2/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.57 |
| ▸ | THRB | P10828 | 1/20 | 0.57 |
| ▸ | CDK2 | P24941 | 1/20 | 0.57 |
| ▸ | CHAT | P28329 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5155525 | 0.90 | FTO (0.57) | FTOMEN1KMT2AMAPTTDP1 | |
| SCHEMBL31326016 | 0.88 | FTO (0.76) | FTOMEN1KMT2AMAPTTDP1 | |
| SCHEMBL29379080 | 0.88 | GNG2 (0.74) | FTOMEN1KMT2AMAPTTDP1 | |
| SCHEMBL112918 | 0.88 | GNG2 (0.74) | FTOMEN1KMT2AMAPTTDP1 | |
| SCHEMBL5364186 | 0.87 | MEN1 (0.62) | FTOMEN1KMT2AMAPTTDP1 | |
| SCHEMBL5066567 | 0.87 | FTO (0.74) | FTOMEN1KMT2AMAPTTDP1 | |
| SCHEMBL3182615 | 0.86 | GNG2 (0.72) | FTOMEN1KMT2AMAPTTDP1 | |
| SCHEMBL3182620 | 0.86 | GNG2 (0.72) | FTOMEN1KMT2AMAPTTDP1 | |
| SCHEMBL5363085 | 0.86 | MEN1 (0.78) | FTOMEN1KMT2AMAPTTDP1 | |
| SCHEMBL8607854 | 0.86 | FTO (0.73) | FTOMEN1KMT2AMAPTTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11561155-B2 | Heavy metal ion-hematein-complexes useful as ex vivo contrast agent for a computed tomography scanning of a biological sample, ex vivo method for investigating a biological sample, and use of the complexes | Technische Universität München (DE) | 2023-01-24 | — | — | US | disclosed |
| US-20210371436-A1 | NOVEL HEAVY METAL ION-LIGAND-COMPLEXES USEFUL AS EX VIVO CONTRAST AGENT FOR A COMPUTED TOMOGRAPHY SCANNING OF A BIOLOGICAL SAMPLE, EX VIVO METHOD FOR INVESTIGATING A BIOLOGICAL SAMPLE, AND USE OF THE COMPLEXES | Technische Universität München (DE) | 2021-12-02 | — | — | US | disclosed |
| US-20200271554-A1 | NOVEL HEAVY METAL ION-HEMATEIN-COMPLEXES USEFUL AS EX VIVO CONTRAST AGENT FOR A COMPUTED TOMOGRAPHY SCANNING OF A BIOLOGICAL SAMPLE, EX VIVO METHOD FOR INVESTIGATING A BIOLOGICAL SAMPLE, AND USE OF THE COMPLEXES | Technische Universität München (DE) | 2020-08-27 | — | — | US | disclosed |
| WO-2019073064-A1 | NOVEL HEAVY METAL ION-HEMATEIN-COMPLEXES USEFUL AS EX VIVO CONTRAST AGENT FOR A COMPUTED TOMOGRAPHY SCANNING OF A BIOLOGICAL SAMPLE, EX VIVO METHOD FOR INVESTIGATING A BIOLOGICAL SAMPLE, AND USE OF THE COMPLEXES | Technische Universität München (DE) | 2019-04-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210371436-A1 | NOVEL HEAVY METAL ION-LIGAND-COMPLEXES USEFUL AS EX VIVO CONTRAST AGENT FOR A COMPUTED TOMOGRAPHY SCANNING OF A BIOLOGICAL SAMPLE, EX VIVO METHOD FOR INVESTIGATING A BIOLOGICAL SAMPLE, AND USE OF THE COMPLEXES | EDNRB, ELANE, CD68 | FTO 3678/4885MEN1 738/4885KMT2A 2849/4885 |
| US-11561155-B2 | Heavy metal ion-hematein-complexes useful as ex vivo contrast agent for a computed tomography scanning of a biological sample, ex vivo method for investigating a biological sample, and use of the complexes | SERPINC1, CD63, CD68 | FTO 4588/4885MEN1 92/4885KMT2A 3751/4885 |
| US-20200271554-A1 | NOVEL HEAVY METAL ION-HEMATEIN-COMPLEXES USEFUL AS EX VIVO CONTRAST AGENT FOR A COMPUTED TOMOGRAPHY SCANNING OF A BIOLOGICAL SAMPLE, EX VIVO METHOD FOR INVESTIGATING A BIOLOGICAL SAMPLE, AND USE OF THE COMPLEXES | SERPINC1, CD63, CD68 | FTO 4620/4885MEN1 121/4885KMT2A 3687/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.